 If 23andme is worth 3.5 billion, its based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits. The post VG Acquisition Stock: The Values in the DNA Vault, Not the Spit Kits appeared first on InvestorPlace. 